Nanostructure-initiator mass spectrometry (NIMS) imaging of brain cholesterol metabolites in Smith-Lemli-Opitz syndrome
- 27 October 2010
- journal article
- Published by Elsevier BV in Neuroscience
- Vol. 170 (3), 858-864
- https://doi.org/10.1016/j.neuroscience.2010.07.038
Abstract
No abstract availableKeywords
Funding Information
- California Institute of Regenerative Medicine (TR1-01219)
- National Institutes of Health (R24 EY017540-04, P30 MH062261-10, P01 DA026146-02)
- NIH/NCRR/STSI (UL1 RR025774)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NIH/NINDS 1 F32 (NS068015-01A1)
This publication has 46 references indexed in Scilit:
- Genetic connections between neurological disorders and cholesterol metabolismJournal of Lipid Research, 2010
- Oxysterols from Free Radical Chain Oxidation of 7-Dehydrocholesterol: Product and Mechanistic StudiesJournal of the American Chemical Society, 2010
- Activation of Rho GTPases in Smith–Lemli–Opitz syndrome: pathophysiological and clinical implicationsHuman Molecular Genetics, 2010
- Detection of Carbohydrates and Steroids by Cation-Enhanced Nanostructure-Initiator Mass Spectrometry (NIMS) for Biofluid Analysis and Tissue ImagingAnalytical Chemistry, 2009
- Central nervous system: cholesterol turnover, brain development and neurodegenerationBiological Chemistry, 2009
- Selective reconstitution of liver cholesterol biosynthesis promotes lung maturation but does not prevent neonatal lethality in Dhcr7 null miceBMC Developmental Biology, 2007
- The use of the Dhcr7 knockout mouse to accurately determine the origin of fetal sterolsJournal of Lipid Research, 2006
- The near universal presence of autism spectrum disorders in children with Smith–Lemli–Opitz syndromeAmerican Journal of Medical Genetics Part A, 2006
- Partial rescue of neonatal lethality of Dhcr7 null mice by a nestin promoter-driven DHCR7 transgene expressionDevelopmental Brain Research, 2005
- AutismPediatric Drugs, 2000